Awareness, perceptions, and choices of physicians pertaining to human papillomavirus (HPV) vaccination in India: A formative research study
- PMID: 36317080
- PMCID: PMC9617192
- DOI: 10.1016/j.jvacx.2022.100228
Awareness, perceptions, and choices of physicians pertaining to human papillomavirus (HPV) vaccination in India: A formative research study
Abstract
Introduction: India accounts for one-fifth of the global burden of cervical cancer cases and mortality. A safe and effective vaccine to prevent human papillomavirus (HPV) infections, the primary cause of cervical malignancies, is available in India but multiple barriers lead to its low uptake in the country. Physicians are a key stakeholder and communicator in the Indian health system and have the potential to increase HPV vaccine uptake.
Objective: We undertook formative research to understand awareness, perceptions and choices of physicians when recommending the HPV vaccine to parents of adolescent girls.
Methods: We conducted in-depth interviews with 32 physicians in two districts of West Bengal. Data collection was carried out between July and August 2019. The data was transcribed, coded, and analyzed using NVivo software using the thematic analysis technique.
Results: Our findings suggest that while physicians are generally aware about the burden of cervical cancer and its prevention by HPV vaccination, they face several barriers to recommending the HPV vaccine routinely and strongly. These include the lack of national-level guidance on the age eligibility and dosage, lack of practice-level opportunities such as well or non-sick visits and other routine adolescent vaccines, practice-level barriers like out-of-pocket cost and vaccine availability, and perceived parental hesitancy arising from reluctance to discuss cervical cancer, its prevention, and HPV vaccination.
Conclusions: Physicians in our study exhibited hesitancy when recommending the HPV vaccine. They also faced logistical barriers. It is important that the barriers pertaining to when and how physicians recommend the vaccine be tackled through further education, policy change, and development and implementation of interventions that are evidenced-based.
Keywords: Awareness; Cervical cancer; HPV vaccination; Human papillomavirus virus; India; Perception; Physician.
© 2022 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Facilitators and barriers of human papillomavirus vaccine uptake in young females 18-26 years old in Singapore: A qualitative study.Vaccine. 2019 Sep 24;37(41):6030-6038. doi: 10.1016/j.vaccine.2019.08.053. Epub 2019 Aug 28. Vaccine. 2019. PMID: 31473002
-
Factors associated with intention-to-recommend human papillomavirus vaccination among physicians in Mysore, India.J Adolesc Health. 2010 Apr;46(4):379-84. doi: 10.1016/j.jadohealth.2009.10.001. Epub 2009 Nov 24. J Adolesc Health. 2010. PMID: 20307828
-
Understanding primary care physician perspectives on recommending HPV vaccination and addressing vaccine hesitancy.Hum Vaccin Immunother. 2021 Jul 3;17(7):1961-1967. doi: 10.1080/21645515.2020.1854603. Epub 2021 Jan 13. Hum Vaccin Immunother. 2021. PMID: 33439768 Free PMC article.
-
Human Papillomavirus Vaccination in South Africa: Programmatic Challenges and Opportunities for Integration With Other Adolescent Health Services?Front Public Health. 2022 Jan 31;10:799984. doi: 10.3389/fpubh.2022.799984. eCollection 2022. Front Public Health. 2022. PMID: 35174123 Free PMC article. Review.
-
Barriers to human papillomavirus vaccine acceptability in Israel.Vaccine. 2013 Nov 22;31 Suppl 8:I53-7. doi: 10.1016/j.vaccine.2013.06.107. Vaccine. 2013. PMID: 24229720 Review.
Cited by
-
Factors associated with HPV vaccine acceptance and hesitancy in Africa: a systematic review protocol.BMJ Open. 2024 Nov 14;14(11):e082592. doi: 10.1136/bmjopen-2023-082592. BMJ Open. 2024. PMID: 39542479 Free PMC article.
-
Cervical cancer kills 300,000 people a year - here's how to speed up its elimination.Nature. 2024 Feb;626(7997):30-32. doi: 10.1038/d41586-024-00241-2. Nature. 2024. PMID: 38291141 No abstract available.
-
Adult vaccination in India: A rapid review of current status & implementation challenges.Indian J Med Res. 2024 Sep&Oct;160(3&4):279-292. doi: 10.25259/IJMR_1521_2024. Indian J Med Res. 2024. PMID: 39632644 Free PMC article. Review.
-
Primary Prevention in Cervical Cancer-Current Status and Way Forward.J Obstet Gynaecol India. 2024 Aug;74(4):287-291. doi: 10.1007/s13224-024-02048-7. Epub 2024 Aug 28. J Obstet Gynaecol India. 2024. PMID: 39280196 Free PMC article.
-
Acceptability of HPV vaccination for cervical cancer prevention amongst emerging adult women in rural Mysore, India: a mixed-methods study.BMC Public Health. 2024 Aug 7;24(1):2139. doi: 10.1186/s12889-024-19485-8. BMC Public Health. 2024. PMID: 39112938 Free PMC article.
References
-
- Global cancer observatory: cancer today. International Agency for Research on Cancer, 2018. (Accessed 11 June, 2020, at https://gco.iarc.fr/today).
-
- Indian Council of Medical Research. Report to the nation on the status of cancer in India; 2014.
-
- Immunization, vaccines and biologicals: human papillomavirus (HPV). 2018. (Accessed 1 June, 2020, at https://www.who.int/immunization/diseases/hpv/en/. .).
-
- To eliminate cervical cancer in the next 100 years, implementing an effective strategy is critical. 2020. (Accessed 11 June, 2020, at https://www.who.int/news-room/detail/04-02-2020-to-eliminate-cervical-ca....).
-
- World Health Organization . World Health Organization; Geneva: 2020. Global strategy to accelerate the elimination of cervical cancer as a public health problem.
LinkOut - more resources
Full Text Sources